lutetium has been researched along with Fibrosarcoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, T; Dash, A; Ghosh, S; Sarma, HD | 1 |
| Banerjee, S; Bhadwal, M; Chakraborty, S; Das, T; Mittal, S; Pillai, MR; Sarma, HD | 1 |
| Banerjee, S; Das, T; Mishra, KP; Sarma, HD; Venkatesh, M; Vidyasagar, PB | 1 |
| Banerjee, S; Chakraborty, S; Das, T; Kagiya, VT; Mukherjee, A; Nair, CK; Samuel, G; Sarma, HD; Venkatesh, M | 1 |
4 other study(ies) available for lutetium and Fibrosarcoma
| Article | Year |
|---|---|
Preparation and Evaluation of
Topics: Animals; Deoxycytidine; Fibrosarcoma; Gemcitabine; Humans; Lutetium; Mice; Molecular Targeted Therapy; Muscles; Radioisotopes; Radiopharmaceuticals; Tissue Distribution | 2017 |
Synthesis and biological evaluation of 177Lu-DOTA-porphyrin conjugate: a potential agent for targeted tumor radiotherapy detection.
Topics: Animals; Feasibility Studies; Female; Fibrosarcoma; Lutetium; Metabolic Clearance Rate; Mice; Molecular Targeted Therapy; Organ Specificity; Porphyrins; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2014 |
Studies on efficacy of a novel 177Lu-labeled porphyrin derivative in regression of tumors in mouse model.
Topics: Animals; Female; Fibrosarcoma; Lutetium; Lymphoma; Mice; Neoplasms, Experimental; Porphyrins; Radioisotopes; Radiopharmaceuticals; Thymus Neoplasms; Tissue Distribution | 2011 |
Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia.
Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Fibrosarcoma; Hypoxia; Lutetium; Mice; Neoplasms; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Triazoles | 2004 |